KFDA likely to approve China’s new flu vaccine in October

Published: 2009-09-10 06:57:00

Updated: 2009-09-10 06:57:00

Boryung BioPharma said that China’s first home-grown H1N1 flu vaccine, which producer Sinovac Biotech Ltd. (NYSE Amex: SVA) says is effective after only one dose, will be approved in this October at the latest, as Korea braces for a feared winter outbreak.

On September 1, Boryung signed an agr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK